Mihael H. Polymeropoulos, M.D.

Mihael H. Polymeropoulos, M.D.

President, Chief Executive Officer and Chairman of the BoardatVanda Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-1% from the year before · Vanda Pharmaceuticals stock +84.1% the same year

Mihael H. Polymeropoulos, M.D. was paid $3.9M in FY2025 (Dec), down 1%. Vanda Pharmaceuticals stock rose 84.1% that year.

Pay$100 in the stock at the end of FY20 → $67
Pay is from the Summary Compensation Table of each Vanda Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vanda PharmaceuticalsPublic company · 5 yr
    • President, Chief Executive Officer and Chairman of the Board2021 – Present · 5 yrStock in role -70%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?